SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 31 filers reported holding SYNTHETIC BIOLOGICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $29,000 | +61.1% | 56,150 | 0.0% | 0.00% | +100.0% |
Q1 2020 | $18,000 | -40.0% | 56,150 | -6.4% | 0.00% | -66.7% |
Q4 2019 | $30,000 | +11.1% | 60,000 | 0.0% | 0.00% | +50.0% |
Q3 2019 | $27,000 | -18.2% | 60,000 | 0.0% | 0.00% | -33.3% |
Q2 2019 | $33,000 | -19.5% | 60,000 | 0.0% | 0.00% | -25.0% |
Q1 2019 | $41,000 | +20.6% | 60,000 | 0.0% | 0.00% | -20.0% |
Q4 2018 | $34,000 | – | 60,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtu Financial LLC | 306,479 | $87,000 | 0.01% |
1620 INVESTMENT ADVISORS, INC. | 15,000 | $4,000 | 0.00% |
Landmark Financial Advisors, LLC | 24,200 | $6,000 | 0.00% |
MSD Partners, L.P. | 116,430 | $33,000 | 0.00% |
IFP Advisors, Inc | 17,650 | $58,000 | 0.00% |
Jacobi Capital Management LLC | 18,500 | $5,000 | 0.00% |
Focused Wealth Management, Inc | 500 | $0 | 0.00% |
JANE STREET GROUP, LLC | 281,700 | $80,000 | 0.00% |
UBS Group AG | 79,851 | $23,000 | 0.00% |
BNP PARIBAS FINANCIAL MARKETS | 1 | $0 | 0.00% |